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skin colonization of the catheter site counted in colony 
forming units per swab at three time points: (1) prior to 
catheter insertion, on untreated skin; (2) directly after cath-
eter insertion, prior to sterile coverage; (3) 48 h after cath-
eter insertion. The hypothesis was tested by a Wilcoxon test 
with a two-sided alpha = 5 %.
Results From second to third swab, recolonization of 
the catheter-surrounding skin was significantly lower in 
the trial group for both sorts of catheters: delta 2–3 OCT 
group: 0.72 (95 % CI: 0.42; 1.02); delta 2–3 BAC group: 
1.97 (95 % CI: 1.45; 2.50); p < 0.001. None of the patients 
enrolled developed a catheter-related blood stream infec-
tion (CRBSI) during follow-up.
Conclusions Previous studies have shown that skin coloni-
zation is strongly associated with the occurrence of CRBSI. 
This randomized controlled trial supports the observations 
made in previous trials that octenidine dihydrochloride in 
disinfectants is more effective than agents containing other 
additives with regard to skin recolonization surrounding 
CVC and EC insertion sites. Therefore, it is likely to also 
reduce the risk of CRBSI in these patient groups. The trial 
was approved by the North Rhine Medical Association in 
July 2014 (application-no.: 2014222).
Keywords Alcoholic disinfection · Catheter-related 
bloodstream infection · Octenidine dihydrochloride · 
Benzalkonium chloride · Central venous catheter · Epidural 
catheter · Bacterial recolonization
Background
Central venous and epidural catheters are commonly 
needed in patients prior to surgery, a variety of invasive 
procedures or in an ICU setting [1, 2]. Many patients suffer 
Abstract 
Purpose Catheter-related bloodstream infections affect 
patients in surgical and intensive care settings worldwide, 
causing complications, aggravation of existing symptoms 
and increased length of stay. The trial aimed at comparing 
two registered skin antiseptics with respect to their residual 
and therefore infection-preventing effects.
Methods In a parallel, monocentric, prospective, triple-
blind, randomized trial the difference in bacterial recoloni-
zation of catheter skin sites in central venous (CVC) and 
epidural catheters (EC) was investigated by comparing 
two alcoholic-based skin disinfectants. Patients receiving 
planned surgeries or intensive care were eligible for the 
trial. Those in the trial group received skin disinfection with 
the additive octenidine dihydrochloride (OCT) (n = 51), 
those in the control group were treated with benzalkonium 
chloride as additive (BAC) (n = 59) prior to catheter inser-
tion. Randomization was carried out by assigning patients 
to groups week-wise. Endpoints of the investigation were 
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from CRBSI originating from poorly disinfected or re-con-
taminated insertion sites around the catheter [3].
The minimization of catheter-surrounding skin recolo-
nization is an effective step to avoid these infections [4], 
which are associated with many consecutive risks and 
cause an increase in treatment costs and lengths of stay [5]. 
As the amount of skin colonization is directly associated 
with catheter colonization and therefore with CRBSI risk, 
it is essential to focus on continuous skin hygiene [6].
Alcohol shows a strong immediate antimicrobial activ-
ity, but has no relevant residual activity on skin. Alcohol 
additives like benzalkonium chloride (BAC), chlorhexidine 
(CHX) or octenidine dihydrochloride (OCT) exert a differ-
ent amount of residual activity on skin once the alcohol’s 
immediate effect has worn off [7]. OCT offers a broad 
and fast acting fungicidal, bactericidal and partly virucidal 
effect in a 0.1 % concentration [8].
Earlier trials have shown the residual activity of some of 
these disinfectants. Particularly, CHX as a strong residual 
agent shows clinical evidence to prevent catheter coloniza-
tion and catheter-related blood stream infections (CRBSI) 
when using CHX/alcohol combinations prior to vascular 
catheter insertion and during catheter care [9].
Similar clinical investigations have proven a residual 
effect for octenidine dihydrochloride which leads to a 
decrease in skin recolonization after the alcohol has evapo-
rated from the skin [10, 11].
The objective of this study was to compare an alcohol-
based skin disinfectant containing OCT with regards to its 




A randomized, prospective, controlled trial was conducted 
to compare the skin recolonization at central venous cath-
eter (CVC) and epidural catheter (EC) insertion sites over 
48 h in patients receiving a skin disinfection with either a 
BAC- or an OCT-containing alcohol-based disinfectant.
Setting and participants
From July to December 2014, 216 patients in an academic 
teaching hospital in Cologne, Germany, were enrolled in 
the trial. The majority of patients received a catheter prior 
to surgery, all others (<2 %) were patients in the Intensive 
Care Unit (ICU).
The Ethical Review Board of the North Rhine Medical 
Association approved the trial in July 2014 (application-
no.: 2014222).
Adult patients likely to receive a CVC or EC or both 
according to pre-operative standards were asked for 
their informed consent. Pre-trial exclusion applied for 
minors, emergency patients and patients with nosocomial 
infections. Patients whose swabs could not be obtained 
according to protocol were excluded. This applied for 
catheters being removed during the follow-up period as 
well as for patients whose sterile dressing did not cover 
the insertion site sufficiently after 48 h. Applying house 
standards according to National Hospital Hygiene Stand-
ards [12], all catheter insertions were carried out by 
experienced anesthesiologists, following a strict proto-
col including the use of surgical masks and caps, sterile 
gowns, gloves and catheter kits. The sterile dressing was 
applied right after the insertion, using a transparent foil 
to facilitate inspection of the insertion site. According to 
the study protocol, nurses or doctors changed the sterile 
cover every 48 h after disinfecting the catheter and its 
surrounding skin with a propranolol spray and a sterile 
pad.
Randomization
The disinfection regimen was changed at weekly intervals, 
thereby randomly assigning patients to the trial or con-
trol group, respectively. The patients, the microbiological 
laboratory and the statistician were blinded to the assign-
ment. The medical staff could not be blinded due to the col-
orant solely in the BAC agent and the use of transparent 
dressings.
After having given their informed consent, patients 
received skin disinfection with either one of the following 
commercially available and legally registered antiseptics:
Trial group
Propan-1-ol 30 % (w/w), propan-2-ol 45 % (w/w), octe-
nidine dihydrochloride (OCT) 0.1 % (w/w) (octeniderm®, 
Schülke & Mayr, Norderstedt, Germany).
Control group
Propan-2-ol 63 % (w/w), benzalkoniumchloride (BAC) and 
coloring agents (Cutasept G®, Paul Hartmann AG, Heiden-
heim, Germany).
The dressing chosen for all patients was a sterile, trans-
parent gauze designed for close skin site monitoring. The 
procedure for the control group was the established hospi-
tal standard, the trial group’s only alteration being the use 
of an alternative disinfectant. The staff only changed their 
routine throughout this trial by taking swabs at the fixed 
time points.
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Settings of the trial
All patients enrolled were treated and followed-up between 
July and December 2014 in the Department of Anaesthesi-
ology at St. Vinzenz-Hospital, Cologne, Germany. Patients 
received catheters prior to surgery in the hospital’s depart-
ments of abdominal, thoracic, gynecological and trauma-
tological surgery or as part of the intensive care or pain 
treatment in the ICU or the department of pain therapy 
respectively. The environment for catheter insertions was 
either the operating theater or the ICU.
Patients who were scheduled for catheters repeatedly 
during the same or various hospitalizations were allowed 
to be enrolled twice (respectively, three times) if at least 
4 weeks had passed since the previous catheterization.
All adult patients scheduled to receive a CVC or EC 
who gave their written consent were included.
To reduce the loss of patients due to protocol devia-
tions, the fixation especially for CVC was improved by 
applying strain-relief to the connected lines. In addition, all 
sterile covers were additionally fixated with adhesive tape 
on the rim. For EC patients, the sterile dressings’ size was 
increased and its rims supported by adhesive tape.
Microbiological methods
All swabs were obtained by trained members of the trial 
team under standardized conditions using a sterile drape 
with a circular hole with a 7 cm diameter. The thereby 
marked skin surrounding the catheter insertion site was 
swiped with a sterile flocked swab (eSwab Liquid Amies, 
Copan, Brescia, Italy) with a movement ten times verti-
cally and ten times horizontally. The tip was then immersed 
in the swabs’ prefilled 1.0 mL sterile 0.01 M phosphate 
buffered saline (PBS) for transport to the microbiological 
laboratory.
To determine the bacterial burden, samples were cul-
tured quantitatively (native, 1:10 and 1:100 dilution) on 
trypticase-soy-agar plates with sheep-blood (bioMérieux, 
Nürtingen, Germany). After vortex mixture, cultures were 
incubated for 36–48 h at 35 ± 1 °C. All tests were run in 
duplicate. The plates were inspected by a technician and 
the supervising microbiologist at 18–24 and 36–48 h. 
Results were expressed as CFU per swab.
Outcomes and follow‑up
Main outcome parameter was the difference in CFUs/swab 
(colony forming units per swab) of swab 3 (i.e. 48 h after 
insertion of CVC or EC) in comparison to swab 2 (i.e. 
immediately after disinfection and insertion). Secondary 
objective was the comparison of swab 3 and swab 1 (i.e. 
before disinfection and insertion). Patients were divided 
into cohorts primarily by skin disinfection regimen and 
secondly by type of catheter, so that four groups could be 
compared (CVC with OCT, CVC with BAC, EC with OCT, 
EC with BAC).
Patients’ comorbidity factors such as smoking, diabetes 
and permanent corticoid therapy were monitored. None of 
the enrolled patients suffered from chronic skin conditions. 
The amount of white blood cells and C-reactive protein 
were also taken into account.
Side effects, such as skin irritation (burning, itching, 
swelling, redness) were also closely monitored.
Statistical analysis
Statistical analysis based on the CFUs counted by the 
laboratory personnel was statistically conducted by the 
University Hospital of Cologne’s Institute for Medi-
cal Statistics, Informatics and Epidemiology (Institut für 
medizinsche Statistik, Informatik und Epidemiologie, 
IMSIE).
The hypothesis was that octenidine as an additive to 
alcoholic skin disinfectants has a longer lasting antimicribi-
ological effect on catheter-surrounding skin than benzalko-
nium chloride.
The analysis was conducted using the Statistical Package 
for the Social Sciences, version 22 (SPSS, IBM, Armonk, 
NY, USA). CFUs counted were logarithmized due to their 
great span. The disinfection regimen was compared at two 
time points: immediately after catheter insertion (swab 2) 
and 48 h after catheter insertion (swab 3). Swab 1 prior to 
skin disinfection was conducted as a baseline, as patients 
with different backgrounds were expected to start off with 
extremely different CFU amounts on their untreated skin. 
The hypothesis was tested by a Wilcoxon test with a two-
sided alpha = 5 %.
Results
216 patients were enrolled in the trial from July to December 
2014. 106 patients had to be excluded from further analysis 
due to manipulation, partial or complete loss of the sterile 
dressing on the insertion site during the first 48 h. Other rea-
sons for exclusion were disinfection within 48 h prior to first 
change of dressings or catheter-removal for therapeutic rea-
sons, and the patient’s death or transferal to another hospital.
After having entered the trial, patients had to be 
excluded due to prematurely removed or loosened sterile 
covers on the catheter site. In addition, patients whose cath-
eters had been removed in the 48 h follow-up period were 
excluded.
Patients entering the trial without any skin colonization 
in the first swab were excluded, as their skin swab result 
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could not be considered a reliable marker. The last reason 
for exclusion was a decrease in skin colonization from 
swab 2 to swab 3.
The remaining 110 patients were divided into two main 
groups (trial, n = 51 and control, n = 59) and into four 
subgroups (trial CVC, n = 25; trial EC, n = 26; control 
CVC, n = 29; control EC, n = 30). A significant difference 
in delta swab 3 to swab 2 and in delta swab 3 to swab 1 was 
expected for both regimens.
Group characteristics
Patients in the trial and control group, even when being cath-
eterized for different reasons, showed similar characteristics 
regarding comorbidity, sex, age and physical constitution.
41 patients received both a CVC and an EC in one ses-
sion, eight entered the trial twice, and one patient was 
enrolled three times in total. At least four weeks had to 
elapse after first catheterization to re-enter again.
Skin colonization
110 patients qualified for skin colonization analysis. There 
was no difference in the immediate effect (i.e. represent-
ing swab 2) between the trial and control group. The dif-
ference in CFUs from swab 2 to swab 3 showed a signifi-
cantly lower value of recolonization in the trial group. In 
the subgroups, additionally divided by type of catheter, 
the values for CVCs were generally higher than for ECs in 
swabs 2 and 3 respectively, the level of recolonization again 
being much lower in the patients treated with OCT. Figure 1 
shows the logarithmized amount of CFUs in all three swabs. 
The direct comparison of trial and control group shows the 
highly significant difference in recolonization from swab 
2 to swab 3, as could be expected. The difference of mean 
values in patients treated with BAC was 1.97 (95 % CI: 
1.45; 2.50), whereas the trial group treated with OCT only 
showed a delta of 0.72 (95 % CI: 0.42; 1.02; p = 0:0005).
Side effects
Side effects such as redness, swelling or pathological serum 
parameters were mild, rare and occurred in all groups. Few 
patients in all groups developed slight redness (n = 7, trial: 
n = 3; control: n = 4) or swelling (n = 3; trial: n = 2; con-
trol: n = 1) around the catheter insertion site (see Fig. 2; 
Table 1). 
Complications
None of the patients developed signs of CRBSI or any 
other systemic side effects, which was expected due to the 
short period of follow-up.
Discussion
This randomized controlled trial is the first to compare the 
immediate and mid-term efficacy over a 48 h period of two 
alcohol-based skin antiseptics used for disinfection of cathe-
ter insertion sites. The trial setup demonstrates similarities in 
the immediate effect and differences in the residual effect of 
the two alcohol-based skin disinfectants. The third skin swab 
taken 48 h after catheter insertion revealed a highly signifi-
cant inhibition of regrowth of the skin flora in the Alcohol/
OCT group in comparison to the Alcohol/BAC group. This 
residual effect of the disinfectant in the trial group can most 
likely be attributed to octenidine dihydrochloride, confirm-
ing results of other clinical studies with this formulation.
Skin colonization is a very important risk and surrogate 
factor for CRBSI [2, 6]. Therefore, the results suggest that 
the use of octenidine-based disinfectants may decrease 
CRBSI risk in CVC and EC patients significantly [6, 13].
For reasons of quality assurance the swab collection 
was limited to a small trial team whose members under-
went a specific training. All swabs were conducted in the 
same manner, e.g. even applying a constant pressure while 
swabbing.
Limitations to the trial are the monocentric setup and 
the relatively small number of patients included in the 
statistical analysis. Nevertheless, regarding antimicro-
bial effect the regimens applied were highly different and 

























Fig. 1  Number of organisms (CFUs/swab) at the insertion sites of 
catheters. CFUs/swab are displayed before, immediately after dis-
infection and 48 h after disinfection with Alcohol/BAC or Alco-
hol/OCT. The difference in colony counts between Alcohol/BAC 
and Alcohol/OCT after 48 h was statistically highly significant 
(p = 0.0005)
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Furthermore, a long-term follow-up was not conducted, as 
the residual effect after initial disinfection was the focus of 
this study. Emergency patients, even though being at high 
risk for CRBSI [14], were excluded from the trial. For a 
long-term follow-up and thus a detection of potential dif-
ferences in the incidence of CRBSIs, a much greater num-
ber of patients would have been needed to be examined, 
which was not possible in this monocentric setup. Further-
more, this study was not powered to answer this question.
The direct comparison of the current standard-antiseptic 
BAC and the octenidine-containing residual agent demon-
strates the latter product’s performance and its potential 
clinical advantage.
The patients’ week-wise assignment to the groups pre-
vented biases such as time of the day, temperatures in 
wards or physician in charge of catheter insertion. Gener-
ally, the patient population was homogenous as all of them 
Fig. 2  Colony forming units at 
the insertion sites of catheters. 
CFUs/swab are displayed 
before, immediately after and 
48 h after disinfection with 
Alcohol/BAC or Alcohol/OCT. 
Sites for CVC and EC are 
shown separately. Statistical 
analyses were carried out within 


































Table 1  Patient characteristics Alcohol/BAC Alcohol/OCT
CVC EC CVC EC
Number of patients 29 30 25 26
Catheter insertion sites 26/0/3 16/10/4 23/1/1 10/14/2
(CVC: jugular vein/subclavian vein/no specification)
(EC: thoracical/lumbal/no specification)
Age (mean) 67.4 66.47 66.8 66,69
Sex (f/m) 12/17 14/16 15/10 11/15
BMI (mean) 25.2 26.15 27 27.7
Diabetes (y/n/not specified) 7/18/4 6/21/3 6/16/3 9/16/1
ASA-classification (I/II/III/IV/ not specified) 0/2/13/1/3 1/15/12/1/1 0/10/11/3/1 0/12/14/0/0
Allergy of any type (y/n/not specified) 4/21/4 6/23/1 6/18/1 7/19/0
Nicotine abuse (y/n/not specified) 9/16/4 12/17/1 5/18/2 3/21/2
Corticoid therapy (y/n/not specified) 3/22/4 0/30/0 3/22/0 1/24/1
Max. CRP (mean) 19 12.15 14.42 9.3
Max. white blood cells (mean) 10.6 12 13.01 9.35
Redness after treatment 2 2 2 1
Swelling after treatment 0 1 1 1
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met criteria for elective surgery that required catheteriza-
tion in advance.
The high number of exclusions is a major limitation 
resulting from three phenomena: especially in the begin-
ning of the trial, many sterile covers on patients’ insertion 
sites detached; the skin underneath could no longer be 
considered sterile. By standardizing the application of ster-
ile dressings, the comparability of CFU results increased. 
Secondly, patients were excluded if they did not show any 
skin colonization in the first swab. Exclusion also resulted 
from a decrease in skin colonization from swab 2 to swab 
3.
Furthermore, full barrier protection and close inspection 
for any early infection signs help to prevent CRBSI [5, 15, 
16]. Regular training on hygiene measures and infection 
prevention also lowers the amount of CRBSI [17, 18].
Conclusions
This RCT showed highly significant differences in micro-
biological skin colonization around CVC and ED insertion 
sites and therefore superiority of an alcohol-based skin dis-
infectant containing OCT in comparison to one containing 
BAC. As other independent trials have shown, OCT is a 
well-tolerated, highly effective skin disinfectant that might 
change the approach in catheter hygiene for both CVC [10, 
11, 19] and EC.
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